Trifarotene (Aklief) for the Treatment of Acne

Document Type

Article

Publication Date

10-15-2020

Abstract

Trifarotene (Aklief) is a topical retinoid labeled for the treatment of facial and truncal acne vulgaris in patients nine years and older.1 Similar to other retinoids, its exact mechanism of action is not known, but it may work by normalizing keratinization and by having anti-inflammatory effects through stimulation of retinoic acid receptors.

Publication Title

American Family Physician

Volume

102

Issue

8

First Page

499

Last Page

504

PubMed ID

33064433

Comments

This article was published in American Family Physician, Volume 102, Issue 8, pages 499-504.

The published version is available at https://www.aafp.org/afp/2020/1015/p499.html.

Copyright © 2020 American Academy of Family Physicians.

This document is currently not available here.

COinS